Cytomedix Inc. Release: Positive Data Demonstrating AutoloGel Provides Rapid Improvement in Healing of Complex Chronic Wounds Published in Advances in Skin and Wound Care

GAITHERSBURG, Md., Aug. 1, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today announced that data demonstrating the Company's AutoloGelâ„¢ System's enhanced formulation of a near-physiological concentration of PRP gel provides rapid and consistent improvement in healing of chronic wounds was published in the August edition of the peer-reviewed journal, Advances in Skin and Wound Care, in an article entitled, "The Clinical Relevance of Treating Chronic Wounds with an Enhanced Near-Physiological Concentration of Platelet-Rich Plasma Gel." The article is available at http://journals.lww.com/aswcjournal/Abstract/2011/08000/The_Clinical_Relevance_of_Treating_Chronic_Wounds.6.aspx.

Back to news